Do Young Kim
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants.
Meinel T, Wilson D, Gensicke H, Scheitz J, Ringleb P, Goganau I, Kaesmacher J, Bae H, Kim D, Kermer P, Suzuki K, Kimura K, Macha K, Koga M, Wada S, Altersberger V, Salerno A, Palanikumar L, Zini A, Forlivesi S, Kellert L, Wischmann J, Kristoffersen E, Beharry J, Barber P, Hong J, Cereda C, Schlemm E, Yakushiji Y, Poli S, Leker R, Romoli M, Zedde M, Curtze S, Ikenberg B, Uphaus T, Giannandrea D, Portela P, Veltkamp R, Ranta A, Arnold M, Fischer U, Cha J, Wu T, Purrucker J, Seiffge D, International DOAC-IVT, TRISP, and CRCS-K-NIH Collaboration, DOAC-IVT Writing Group, Kägi G, Engelter S, Nolte C, Kallmünzer B, Michel P, Kleinig T, Fink J, Rønning O, Campbell B, Nederkoorn P, Thomalla G, Kunieda T, Poli K, Béjot Y, Soo Y, Garcia-Esperon C, Ntaios G, Cordonnier C, Marto J, Bigliardi G, Lun F, Choi P, Steiner T, Ustrell X, Werring D, Wegener S, Pezzini A, Du H, Martí-Fàbregas J, Cánovas-Vergé D, Strbian D, Padjen V, Yaghi S, Stretz C, Kim J. Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants. JAMA Neurol 2023; 80:233-243.
Mar 1, 2023Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants.
Mar 1, 2023JAMA Neurol 2023; 80:233-243
Meinel Thomas Raphael, Wilson Duncan, Gensicke Henrik, Scheitz Jan F, Ringleb Peter Arthur, Goganau Ioana, Kaesmacher Johannes, Bae Hee-Joon, Kim Do Young, Kermer Pawel, Suzuki Kentaro, Kimura Kazumi, Macha Kosmas, Koga Masatoshi, Wada Shinichi, Altersberger Valerian L, Salerno Alexander, Palanikumar Logesh, Zini Andrea, Forlivesi Stefano, Kellert Lars, Wischmann Johannes, Kristoffersen Espen, Beharry James, Barber P Alan, Hong Jae Beom, Cereda Carlo Walter, Schlemm Eckhard, Yakushiji Yusuke, Poli Sven, Leker Ronen R, Romoli Michele, Zedde Marialuisa, Curtze Sami, Ikenberg Benno, Uphaus Timo, Giannandrea David, Portela Pere Cardona, Veltkamp Roland, Ranta Annemarei, Arnold Marcel, Fischer Urs, Cha Jae-Kwan, Wu Teddy Y, Purrucker Jan C, Seiffge David Julian, International DOAC-IVT, TRISP, and CRCS-K-NIH Collaboration, DOAC-IVT Writing Group, Kägi Georg, Engelter Stefan T, Nolte Christian H, Kallmünzer Bernd, Michel Patrik, Kleinig Timothy, Fink John, Rønning Ole Morten, Campbell Bruce C V, Nederkoorn Paul J J, Thomalla Götz, Kunieda Takenobu, Poli Khouloud, Béjot Yannick, Soo Yannie, Garcia-Esperon Carlos, Ntaios Georges, Cordonnier Charlotte, Marto João Pedro, Bigliardi Guido, Lun François, Choi Philip M C, Steiner Thorsten, Ustrell Xavier, Werring David J, Wegener Susanne, Pezzini Alessandro, Du Houwei, Martí-Fàbregas Joan, Cánovas-Vergé David, Strbian Daniel, Padjen Visnja, Yaghi Shadi, Stretz Christoph, Kim Joon-Tae
Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial
Hatemi G, Chen M, Paris M, McCue S, Cheng S, Melikoğlu M, Direskeneli H, Saadoun D, Kim D, Takeno M, Mahr A, Yazici Y. Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial. Clin Exp Rheumatol 2021; 39 Suppl 132:80-87.
Oct 6, 2021Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial
Oct 6, 2021Clin Exp Rheumatol 2021; 39 Suppl 132:80-87
Hatemi Gülen, Chen Mindy, Paris Maria, McCue Shannon, Cheng Sue, Melikoğlu Melike, Direskeneli Haner, Saadoun David, Kim Do Young, Takeno Mitsuhiro, Mahr Alfred, Yazici Yusuf